Robert Boyle is a CEO at Sentinel Oncology. He possess expertise in drug discovery, medicinal chemistry, organic chemistry, biotechnology, oncology and 13 more skills. Colleagues describe him as "Bob is an exceptionally creative and highly accomplished scientist/individual and has the ability to see a way through the most complex of issues. He has a deep understanding of drug discovery and development and is also highly regarded amongst his peers, direct reports, and superiors alike. Bob is widely acknowledged as a talented leader and manager and has a natural ability bring together high performing teams to achieve the most demanding of goals."